FDA Accomplishments for the American People
FDA Seizes 7-OH Opioids to Protect American Consumers
The U.S. Food and Drug Administration, in coordination with the U.S. Department of Justice, announced today that the U.S. Marshals Service seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products—valued at roughly $1 million—from three firms in Missouri.
Read MoreRecalls, Market Withdrawals, & Safety Alerts
Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this website.
Jan 23
Navitas Organics Voluntarily Recalls Select Lots of 8oz Organic Chia Seeds Because of Possible Health Risk
Food & Beverages
Jan 23
IKM Recalls Product Because of Possible Health Risk
Food & Beverages
Jan 16
Tri-Union Seafoods Identifies Additional Quantities of Recalled Genova® Tuna at Limited Retailers Due to Inadvertent Distribution of Previously Recalled Product
Food & Beverages
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA Encourages Development of New, Reliable Alternatives to Animal Testing in Sunscreen
FDA strongly encourages companies to continue to develop new, reliable ways to minimize animal testing.
FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity
The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.
FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program
ISTAND supports innovative, science-driven approaches that improve drug development and regulatory decision-making.
Recently Published Guidances
Jan 23
Cuffless Non-invasive Blood Pressure Measuring Devices – Clinical Performance Testing and Evaluation
Medical Devices
Jan 21
FDA Records Access Authority for Cosmetic Products
Cosmetics
Jan 21
Minimal Residual Disease and Complete Response in Multiple Myeloma: Use as Endpoints to Support Accelerated Approval